The Most Promising Ebola Vaccine Has Been Sitting on the Shelf for 15 Years
A race to develop vaccines for the Bundibugyo strain of Ebola is underway, including a candidate that has existed for 15 years.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
BARDA initiated a $75 million sprint to develop vaccines against the Bundibugyo strain of Ebola, with three new vaccines under development. Some candidates were expected to enter Phase 1 trials as early as July.
The story quieted without a definitive conclusion in the coverage.
Epilogue added 4d ago, after coverage quieted.
The brief
An Ebola outbreak is widening, prompting the development of three new vaccines specifically targeting the Bundibugyo strain. BARDA has initiated a $75 million sprint to accelerate these efforts, as existing vaccines are reported to be ineffective against this particular outbreak.
Coverage from Reuters, WIRED, and The New York Times emphasizes the urgency of testing treatments. According to Reuters, vaccine candidates could enter Phase 1 trials as early as July.
Other outlets, including The Japan Times and Edition.mv, are tracking the various vaccines and treatments currently in development. Future developments center on the progression of the three new vaccines and the results of the upcoming Phase 1 trials.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 19d ago.
Quick answers
Which strain of Ebola is the current focus of vaccine development?
The vaccines are being developed to target the Bundibugyo strain.
How much funding has BARDA allocated for this effort?
BARDA has launched a $75 million sprint for the Bundibugyo Ebola vaccine.
When might the vaccine candidates enter Phase 1 trials?
According to Reuters, they could enter Phase 1 trials as early as July.
Coverage (8)
- Three new vaccines are being developed against the Bundibugyo strain of Ebola virus Radar Armenia · 22d ago
- BARDA's Vaccine Engine Roars Back: $75 Million Bundibugyo Ebola Vaccine Sprint Begins trialsitenews.com · 22d ago
- The vaccines and treatments being developed for Ebola outbreak Edition.mv · 22d ago
- The vaccines and treatments being developed for Ebola outbreak The Japan Times · 22d ago
- Ebola Bundibugyo vaccine candidates could enter Phase 1 trials as early as July Reuters · 22d ago
- Why existing vaccines won’t help this Ebola outbreak National Geographic · 22d ago
- Scientists Race to Test Treatments as Ebola Outbreak Widens The New York Times · 22d ago
- The Most Promising Ebola Vaccine Has Been Sitting on the Shelf for 15 Years WIRED · 22d ago
Topics
Related trends
U.S. Citizen Tests Positive for Ebola in Democratic Republic of Congo
Multiple U.S. citizens have tested positive for the Ebola virus while working in the Democratic Republic of Congo.
Genomic epidemiology of the ongoing 2026 Bundibugyo Virus Disease outbreak in the Democratic Republic of the Congo
Genomic data and logistics challenges highlight the ongoing 2026 Bundibugyo Virus Disease outbreak in the Democratic Republic of the Congo.
New Congo province has suspected Ebola case as deaths hit 600, report says
8 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Ebola outbreak in Congo still spreading, WHO says
7 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
There's no treatment designed for the Ebola strain ravaging DRC. But now there's hope
New clinical trials and expanded medical facilities offer hope for a viral Ebola strain in the Democratic Republic of Congo that lacks a specific treatment.
Ebola deaths in Congo top 500 as health workers threaten to strike
9 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.